Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J packs up HIV vaccine after failing phase 3 trial
Fierce Biotech
Wed, 01/18/23 - 11:06 am
Tags:
JNJ, vaccines, HIV, HIV vaccines, clinical trials
Few big bangs in a quiet year for medtech mergers
EP Vantage
Wed, 01/11/23 - 10:46 am
Tags:
M&A, Medtech, JNJ, Abiomed, Quidelortho, Ortho Clinical Diagnostics, Coloplast, Atos Medical, ICU Medical, Smiths Medical, Boston Scientific, Baylis Medical
JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says
Fierce Pharma
Tue, 01/10/23 - 06:32 pm
Tags:
JNJ, Horizon Therapeutics, M&A
JPM Day 1: Highlights
BioSpace
Mon, 01/9/23 - 11:01 pm
Tags:
JPMHC 2023, Sarepta Therapeutics, Biomarin, Alnylam, JNJ, Arrowhead Pharmaceuticals, Novartis, Bristol Myers Squibb
Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report
Fierce Pharma
Sun, 01/8/23 - 09:57 pm
Tags:
Pfizer, Merck, JNJ, Novo Nordisk, AstraZeneca
Fate hits reset as J&J cell therapy deal collapses, slashing pipeline and head count to stretch cash
Fierce Biotech
Fri, 01/6/23 - 09:43 am
Tags:
Fate Therapeutics, JNJ, cell therapy, layoffs
Ready for takeoff: J&J's consumer health unit Kenvue files for official separation
Endpoints
Thu, 01/5/23 - 05:02 pm
Tags:
JNJ, IPOs, consumer health, Kenvue, spinoffs
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Tags:
Pfizer, Merck, JNJ, Novartis, AbbVie, Roche
Biggest Medtech Winners Going into 2023
Medical Devices and Diagnostics Industry
Tue, 01/3/23 - 10:00 am
Tags:
Medtech, digital health, hearing aids, JNJ, Abiomed, M&A, device manufacturing, semiconductors, women executives
Johnson & Johnson is Investing Billions in Clinical Care Solutions
Forbes
Wed, 12/28/22 - 08:30 pm
Tags:
JNJ, Abiomed, M&A
J&J leads $85M investment in HistoSonics ahead of liver cancer device authorization
Medtech Dive
Wed, 12/14/22 - 10:41 am
Tags:
JNJ, funding, venture capital, HistoSonics, liver cancer, Medtech, Edison, devices, JNJ Innovation
J&J’s next myeloma drug, Argenx’s second act and a new question for Bluebird: 3 ASH takeaways
BioPharma Dive
Mon, 12/12/22 - 10:56 pm
Tags:
ASH 2022, JNJ, talquetamab, Multiple Myeloma, Argenx, Bluebird Bio, Vyvgart, ITP
Gilead lands new cell therapy for Kite in $225M Arcellx deal
Fierce Biotech
Fri, 12/9/22 - 10:37 am
Tags:
Gilead Sciences, Kite Pharma, Arcellx, clinical trials, Multiple Myeloma, cell therapy, JNJ, Legend Biotech
On its annual list of price hike offenders, ICER calls out Bausch's Xifaxan, J&J's Invega
Fierce Pharma
Wed, 12/7/22 - 10:10 am
Tags:
ICER, drug pricing, Bausch Health, Xifaxan, JNJ, Invega
Janssen Bows Out as Contender for Horizon Therapeutics Buyout
BioSpace
Mon, 12/5/22 - 10:59 am
Tags:
Horizon Therapeutics, M&A, Agmen, Sanofi, Janssen, JNJ
Alex Gorsky to step down as J&J chair in 2023
Medical Marketing and Media
Thu, 12/1/22 - 10:57 am
Tags:
Alex Gorsky, JNJ, Pharma CEOs, Joaquin Duato
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
Tags:
JNJ, Janssen, Amgen, legal, ulcerative colitis, patents, Stelara
J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step
Fierce Biotech
Thu, 12/1/22 - 10:33 am
Tags:
JNJ, AC Immune, Alzheimer's disease, Janssen, vaccines, ACI-35.030
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Tags:
Horizon Pharma, M&A, JNJ, Sanofi, Amgen
J&J Vision Sets Sights on Sustainability
Medical Devices and Diagnostics Industry
Wed, 11/30/22 - 10:39 am
Tags:
JNJ, Medtech, JNJ Vision, sustainability

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.